Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O D Bragina

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Naturae|August 4, 2022
The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast CancerO D Bragina, S M Deyev, V I Chernov, et al.
Vestnik Rentgenologii I Radiologii|September 25, 2018
[Radionuclide teranostic of malignancies]V I Chernov, O D Bragina, I G Sinilkin, et al.
Acta Naturae|January 2, 2026
Targeted Radionuclide Detection of Malignant Tumors Using AffibodyO D Bragina, A A Nesynov, E Yu Sitnikova, et al.
Voprosy Onkologii|November 17, 2018
[Radioimmunotherapy: current state of the problem]V I Chernov, O D Bragina, I G Sinilkin, et al.
NPJ Systems Biology and Applications|July 7, 2025
Single-cell transcriptomic profiling of immune landscape in triple-negative breast cancer during neoadjuvant chemotherapyM R Patysheva, P S Iamshchikov, A A Fedorenko, et al.
Bulletin of Experimental Biology and Medicine|September 28, 2023
Preparation of a Single-Cell Suspension from Tumor Biopsy Samples for Single-Cell RNA SequencingA A Frolova, T S Gerashchenko, M R Patysheva, et al.
Acta Naturae|August 27, 2024
Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [99mTc]Tc-(HE)3-G3O D Bragina, L A Tashireva, D M Loos, et al.
Scientific Reports|December 5, 2022
Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancerE S Grigoryeva, L A Tashireva, V V Alifanov, et al.
Scientific Reports|May 28, 2024
EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patientsV M Perelmuter, E S Grigoryeva, O E Savelieva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Naturae|August 4, 2022
The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast CancerO D Bragina, S M Deyev, V I Chernov, et al.
Vestnik Rentgenologii I Radiologii|September 25, 2018
[Radionuclide teranostic of malignancies]V I Chernov, O D Bragina, I G Sinilkin, et al.
Acta Naturae|January 2, 2026
Targeted Radionuclide Detection of Malignant Tumors Using AffibodyO D Bragina, A A Nesynov, E Yu Sitnikova, et al.
Voprosy Onkologii|November 17, 2018
[Radioimmunotherapy: current state of the problem]V I Chernov, O D Bragina, I G Sinilkin, et al.
NPJ Systems Biology and Applications|July 7, 2025
Single-cell transcriptomic profiling of immune landscape in triple-negative breast cancer during neoadjuvant chemotherapyM R Patysheva, P S Iamshchikov, A A Fedorenko, et al.
Bulletin of Experimental Biology and Medicine|September 28, 2023
Preparation of a Single-Cell Suspension from Tumor Biopsy Samples for Single-Cell RNA SequencingA A Frolova, T S Gerashchenko, M R Patysheva, et al.
Acta Naturae|August 27, 2024
Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [99mTc]Tc-(HE)3-G3O D Bragina, L A Tashireva, D M Loos, et al.
Scientific Reports|December 5, 2022
Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancerE S Grigoryeva, L A Tashireva, V V Alifanov, et al.
Scientific Reports|May 28, 2024
EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patientsV M Perelmuter, E S Grigoryeva, O E Savelieva, et al.
Pageof 1